N. Chrysson

Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer.

J. Carmichael, F. Shepherd, J. von Pawel, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ha-ras polymorphisms in epithelial ovarian cancer.

A. Berchuck, F. Tyson, K. O'briant, 1992, Gynecologic oncology.

Feasibility and acceptability of brief behavioral therapy for cancer-related insomnia: effects on insomnia and circadian rhythm during chemotherapy: a phase II randomised multicentre controlled trial

S. Kesler, C. Heckler, K. Mustian, 2018, British Journal of Cancer.

Secondary Outcomes of a Behavioral Sleep Intervention: A Randomized Clinical Trial

S. Kesler, C. Heckler, R. Gevirtz, 2019, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

41 Preliminary results of a randomized comparative phase III trial of topotecan (T) versus CAV as second-line therapy of small cell lung cancer (SCLC)

J. Schiller, S. Fields, J. Kleisbauer, 1997 .